 |
|
Effects of the Revised Reimbursement Guideline for Anti-Osteoporosis Medication in South Korea
Young-Seung Ko, Yeonsuk Jeong, Jung-Wee Park, Young-Kyun Lee, Kyung-Hoi Koo
J Bone Metab. 2022;29(3):191-196. Published online 2022 Aug 31 DOI: https://doi.org/10.11005/jbm.2022.29.3.191
|
|
Citations to this article as recorded by
 Impact of the guidance on fracture Liaison Services and the introduction of a new fee for secondary fracture prevention in Japan: Implementation of secondary fracture prevention during hospitalization for fragility fractures
Gaku Gondo, Jung-ho Shin, Susumu Kunisawa, Yuichi Imanaka
Osteoporosis International.2025; 36(2): 235. CrossRef Period prevalence and timing of contralateral hip fractures: An eighteen year retrospective cohort study, systematic review and meta-analysis of the literature
David Morris, Tim Cheok, Thomas Smith, Jonghoo Sung, Ruurd Jaarsma, Luke Johnson
Bone.2025; 195: 117453. CrossRef
|